However, the role of specific ALDH isoforms, such as ALDH1A1, ALDH1A3, ALDH2, and ALDH3A1, as CSC markers has shifted attention towards developing targeted inhibitors to prevent cancer progression. This evidence concerns the gene ALDH3A1 and cancer.